GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Return-on-Tangible-Asset

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Return-on-Tangible-Asset : 6.48% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Carl Zeiss Meditec AG Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Carl Zeiss Meditec AG's annualized Net Income for the quarter that ended in Dec. 2023 was $163 Mil. Carl Zeiss Meditec AG's average total tangible assets for the quarter that ended in Dec. 2023 was $2,516 Mil. Therefore, Carl Zeiss Meditec AG's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 6.48%.

The historical rank and industry rank for Carl Zeiss Meditec AG's Return-on-Tangible-Asset or its related term are showing as below:

CZMWF' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 7.05   Med: 10.45   Max: 14.46
Current: 12.56

During the past 13 years, Carl Zeiss Meditec AG's highest Return-on-Tangible-Asset was 14.46%. The lowest was 7.05%. And the median was 10.45%.

CZMWF's Return-on-Tangible-Asset is ranked better than
89.33% of 862 companies
in the Medical Devices & Instruments industry
Industry Median: -2.075 vs CZMWF: 12.56

Carl Zeiss Meditec AG Return-on-Tangible-Asset Historical Data

The historical data trend for Carl Zeiss Meditec AG's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Return-on-Tangible-Asset Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.56 8.21 13.67 13.28 13.34

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.14 11.81 17.76 14.45 6.48

Competitive Comparison of Carl Zeiss Meditec AG's Return-on-Tangible-Asset

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Return-on-Tangible-Asset falls into.



Carl Zeiss Meditec AG Return-on-Tangible-Asset Calculation

Carl Zeiss Meditec AG's annualized Return-on-Tangible-Asset for the fiscal year that ended in Sep. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=309.921/( (2131.427+2516.171)/ 2 )
=309.921/2323.799
=13.34 %

Carl Zeiss Meditec AG's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=163.14/( (2516.171+0)/ 1 )
=163.14/2516.171
=6.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data.


Carl Zeiss Meditec AG  (OTCPK:CZMWF) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Carl Zeiss Meditec AG Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.